Coya Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Coya Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Coya Therapeutics Inc
Rating: 1.27141675
Author: Trendlyne DVM scores

about

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune,...

5.53 -0.14 (-2.47%)

46.00% Fall from 52W High

18,841

XNAS Volume

XNAS 17 Sep, 2025 9:41 AM (EDT)

Not Eligible

Expensive Valuation

6.2 / 100

Technically Neutral

44.7 / 100

1Yr Price target upside is 201%

7 analysts

Coya Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Coya Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune,...

46.00% Fall from 52W High

SWOT Analysis

Coya Therapeutics Inc Live Price Chart